Carroll Financial Associates, Inc. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 84 filers reported holding CRISPR THERAPEUTICS AG in Q4 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q4 2021$17,000
-32.0%
2250.0%0.00%0.0%
Q3 2021$25,000
-30.6%
2250.0%0.00%
-50.0%
Q2 2021$36,000
-58.6%
225
-68.7%
0.00%
-60.0%
Q1 2021$87,000
-23.7%
719
-4.1%
0.01%
-37.5%
Q4 2020$114,000
+83.9%
7500.0%0.01%
+60.0%
Q3 2020$62,000
-6.1%
750
-16.7%
0.01%
-16.7%
Q2 2020$66,000
+247.4%
900
+100.0%
0.01%
+200.0%
Q1 2020$19,000
-29.6%
4500.0%0.00%0.0%
Q4 2019$27,000
+50.0%
4500.0%0.00%0.0%
Q3 2019$18,000
-14.3%
4500.0%0.00%0.0%
Q2 2019$21,000
+31.2%
4500.0%0.00%
+100.0%
Q1 2019$16,000
+6.7%
4500.0%0.00%
-50.0%
Q4 2018$15,000
-21.1%
4500.0%0.00%0.0%
Q3 2018$19,000
-26.9%
4500.0%0.00%
-33.3%
Q2 2018$26,000
+30.0%
4500.0%0.00%
+50.0%
Q1 2018$20,000
+100.0%
4500.0%0.00%
+100.0%
Q4 2017$10,000
+25.0%
4500.0%0.00%0.0%
Q3 2017$8,000
+14.3%
4500.0%0.00%0.0%
Q2 2017$7,000
-22.2%
4500.0%0.00%0.0%
Q1 2017$9,0004500.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,608,874$160,053,562,00054.44%
Abingworth LLP 1,237,202$54,858,00032.62%
NEA Management Company, LLC 2,090,678$92,722,0004.00%
New Leaf Venture Partners, L.L.C. 444,708$19,723,0003.59%
EcoR1 Capital, LLC 500,000$22,175,0002.00%
ARK Investment Management 1,453,590$64,467,0001.95%
CLOUGH CAPITAL PARTNERS L P 337,731$14,978,0001.41%
Casdin Capital, LLC 220,000$9,757,0001.19%
Valiant Capital Management, L.P. 271,700$12,050,0001.07%
Monashee Investment Management LLC 110,000$4,879,0001.03%
View complete list of CRISPR THERAPEUTICS AG shareholders